Comparative Cohort Study of Long-term Safety Outcomes of Risankizumab Compared to Biologic Treatments for Ulcerative Colitis and Crohn’s Disease in a Real-world Setting in Sweden and Denmark

01/07/2024
07/08/2025
EU PAS number:
EUPAS1000000151
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

P23654_Risa_CD-Study_abstract_Redacted.pdf

English (135.76 KB - PDF) View document
Updated protocol

P23654_Risa_IBD_abstract_3June2025_Redacted.pdf

First published: 30/06/2025
English (102.03 KB - PDF) View document
Study results
Study report
Other information
Study, other information

DoI_combined_risa IBD.pdf

English (374.74 KB - PDF) View document